Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors-Reference-Cited by-同舟云学术

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

Published:1992-01 Issue:2 Volume:1123 Page:133-144
ISSN:0005-2760
Container-title:Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism

Author:

Bocan Thomas M.A.,Ferguson Erika,McNally William,Uhlendorf Paul D.,Mueller Sandra Bak,Dehart Peter,Sliskovic Drago R.,Roth Bruce D.,Krause Brian R.,Newton Roger S.

Publisher

Elsevier BV

Subject

Endocrinology,Biochemistry,Biophysics

Reference27 articles.

1. A Receptor-Mediated Pathway for Cholesterol Homeostasis

2. Hep-G2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductase

3. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

4. A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase

5. Inhibition of cholesterol synthesis by lovastatin tested on six human cell typesin vitro

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-administration of CSL112 (apolipoprotein A-I [human]) with atorvastatin and alirocumab is not associated with increased hepatotoxic or toxicokinetic effects in rats;Toxicology and Applied Pharmacology;2021-07

2. Atherosclerosis: Cholesterol Management;Burger's Medicinal Chemistry and Drug Discovery;2021-04-22

3. Synthesis and Anti-Inflammatory Activity of Some O-Propargylated-N-acetylpyrazole Derived from 1,3-Diarylpropenones;International Journal of Medicinal Chemistry;2016-01-11

4. Inhibition of Cholesterol Biosynthesis;Drug Discovery and Evaluation: Pharmacological Assays;2016

5. Inhibition of Cholesterol Biosynthesis;Drug Discovery and Evaluation: Pharmacological Assays;2015